模拟教学与互动移动学习在ECMO教学中的随机对照试验
干预后模拟组笔试知识得分(90.0%)高于QuizTime组(70.0%)和无训练组(75.0%),差异有统计学意义。4个月时三组知识得分无差异,但模拟组在模拟评估中关键动作时间更短。结果表明模拟教学可改善ECMO知识获取和部分操作表现,但长期保留效果需进一步研究。
要点
- 模拟组干预后笔试知识得分中位数90.0%,高于QuizTime组70.0%(p=0.0003)和无训练组75.0%(p=0.001)。
- 4个月随访时三组知识得分无显著差异(p>0.05)。
- 干预后模拟评估中,模拟组关键动作时间80.0秒,短于QuizTime组300.0秒(p=0.02)。
- 4个月时模拟组关键动作时间45.0秒,短于QuizTime组255.5秒(p=0.008)和无训练组300.0秒(p=0.009)。
适用人群与场景
- (本栏提炼含原文里核对不到的数值,已删除,请以原文为准)
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 模拟组:接受三次高保真训练场景。
- QuizTime组:通过移动设备在3周内接收共15道多选题。
- 经验组:无正式训练。
- 所有参与者在随机化前、干预后立即和干预后4个月完成调查、笔试和模拟评估。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 人群:危重症临床医生,ECMO经验有限。
- 干预与对照:模拟组(n=15)vs QuizTime组(n=14)vs 经验组(n=15)。
- 主要终点:干预后立即笔试知识得分,模拟组90.0%(IQR 85.0-90.0%)高于QuizTime组70.0%(IQR 65.0-80.0%;p=0.0003)和经验组75.0%(IQR 65.0-80.0%;p=0.001)。
- 关键次要终点:4个月时知识得分三组无差异(p>0.05);干预后模拟评估关键动作时间模拟组80.0秒(IQR 54.0-111.0秒)短于QuizTime组300.0秒(IQR 85.0-300.0秒;p=0.02);4个月时模拟组45.0秒(IQR 34.0-92.5秒)短于QuizTime组255.5秒(IQR 102.0-300.0秒;p=0.008)和经验组300.0秒(IQR 58.0-300.0秒;p=0.009)。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:随机对照试验。
- 证据等级或推荐强度:原文未提及。
对床旁实践的改变
- 对于ECMO经验有限的危重症临床医生,高保真模拟教学可在短期内提高ECMO知识得分和模拟操作中的关键动作速度,优于移动学习或无正式训练。
- 模拟教学对4个月知识保留的优势不明显,需结合其他方法巩固长期记忆。
- 本研究样本量小且为单中心,结论外推需谨慎,对患者结局的影响尚未明确。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Extracorporeal membrane oxygenation has become integral to critical care. Data informing optimal extracorporeal membrane oxygenation education modalities are lacking. We aimed to compare the effect of high-fidelity simulation versus interactive mobile learning on extracorporeal membrane oxygenation knowledge acquisition and retention among clinicians.
DESIGN: Observer-blinded, randomized controlled trial.
SETTING: A single academic medical center.
SUBJECTS: Forty-four critical care clinicians with limited extracorporeal membrane oxygenation experience.
INTERVENTIONS: Participants were randomized to receive: 1) simulation: three high-fidelity training scenarios, 2) QuizTime: 15 total multiple-choice questions delivered over 3 weeks via mobile device, or 3) experiential: no formal training. Participants completed a survey, written knowledge examination, and simulation assessment prior to randomization, immediately following the intervention, and 4 month postintervention.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was knowledge about extracorporeal membrane oxygenation assessed by score on the immediate postintervention written examination. Secondary outcomes included performance in extracorporeal membrane oxygenation simulation postintervention and 4 months later assessed by a rater blinded to group assignment. Clinicians randomized to simulation (n = 15), QuizTime (n = 14), and experiential (n = 15) had similar baseline characteristics. Adjusting for baseline knowledge, postintervention examination scores were higher in the simulation group (90.0%; interquartile range, 85.0-90.0%) than the QuizTime group (70.0%; interquartile range, 65.0-80.0%; p = 0.0003) and the experiential group (75.0%; interquartile range, 65.0-80.0%; p = 0.001). Scores did not differ between the groups at 4 months (p > 0.05 in all analyses). In postintervention extracorporeal membrane oxygenation simulations, the simulation group demonstrated shorter time to critical action compared with QuizTime (80.0 s [interquartile range, 54.0-111.0 s] vs 300.0 s [interquartile range 85.0-300.0 s]; p = 0.02) and compared with both QuizTime (45.0 s [interquartile range, 34.0-92.5 s] vs 255.5 s [interquartile range, 102.0-300.0 s]; p = 0.008) and experiential (300.0 s [interquartile range, 58.0-300.0 s]; p = 0.009) at 4 months.
CONCLUSIONS: Simulation was superior to QuizTime and experiential learning with regard to extracorporeal membrane oxygenation knowledge acquisition. Further studies are needed to ascertain the effect of these interventions on knowledge retention, clinical performance, and patient outcomes.
参考来源
- Gannon WD, Stokes JW, Pugh ME, et al. Simulation Versus Interactive Mobile Learning for Teaching Extracorporeal Membrane Oxygenation to Clinicians: A Randomized Trial. Crit Care Med. 2021. PMID: 34678847. doi:10.1097/CCM.0000000000005376
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。